What is the recommended vasopressin dosing for an adult with septic (vasodilatory) shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vasopressin Dosing for Septic Shock

For adults with septic (vasodilatory) shock, start vasopressin at 0.03 units/minute as a second-line agent added to norepinephrine, with a maximum dose of 0.03-0.04 units/minute for routine use. 1, 2

Initial Vasopressor Strategy

  • Norepinephrine is the mandatory first-line vasopressor for septic shock, targeting a mean arterial pressure (MAP) of 65 mmHg after administering at least 30 mL/kg crystalloid resuscitation. 1

  • Vasopressin should never be used as monotherapy—it must be added to norepinephrine, not used as the sole initial vasopressor. 1

When to Add Vasopressin

  • Add vasopressin when norepinephrine alone fails to maintain adequate MAP despite appropriate fluid resuscitation, or when you need to decrease norepinephrine dosage while maintaining hemodynamic stability. 1

  • The Society of Critical Care Medicine recommends adding vasopressin to raise MAP to target or to spare norepinephrine when maximum doses of initial vasopressor cannot achieve target MAP. 1

Specific Dosing Protocol

FDA-approved dosing for septic shock: 2

  • Starting dose: 0.01 units/minute
  • Dose range: 0.01-0.07 units/minute
  • Standard dose when added to norepinephrine: 0.03 units/minute 1
  • Maximum routine dose: 0.03-0.04 units/minute 1

Titration approach: 1

  • Start at 0.01 units/minute
  • Titrate up by 0.005 units/minute at 10-15 minute intervals
  • Target MAP ≥65 mmHg
  • Do not exceed 0.03-0.04 units/minute for routine use

Critical Dose Ceiling

  • Doses higher than 0.03-0.04 units/minute should be reserved for salvage therapy only (when other vasopressors have failed to achieve target MAP). 1

  • Vasopressin doses above 0.03-0.04 units/minute are associated with cardiac, digital, and splanchnic ischemia. 1

Administration Requirements

  • Dilute the 20 units/mL vial with normal saline or 5% dextrose to either 0.1 units/mL or 1 unit/mL for intravenous administration. 2

  • Discard unused diluted solution after 18 hours at room temperature or 24 hours under refrigeration. 2

  • Administer through central venous access with continuous arterial blood pressure monitoring via arterial catheter. 1

Escalation Strategy for Refractory Shock

If target MAP is not achieved with norepinephrine plus vasopressin at 0.03 units/minute: 1

  • Add epinephrine (0.05-2 mcg/kg/min) as a third vasopressor agent rather than increasing vasopressin beyond 0.03-0.04 units/minute

  • Consider dobutamine (up to 20 mcg/kg/min) if persistent hypoperfusion exists despite adequate MAP and vasopressor therapy, particularly when myocardial dysfunction is evident

  • Consider hydrocortisone 200 mg/day for refractory shock when hemodynamic stability cannot be achieved despite adequate fluid resuscitation and vasopressor therapy 3

Common Pitfalls to Avoid

  • Do not titrate vasopressin like a traditional vasopressor—use the fixed dose of 0.03 units/minute rather than continuously escalating. 1

  • Do not delay norepinephrine initiation—vasopressin is always a second-line agent, never first-line. 1

  • Do not exceed 0.04 units/minute except in salvage situations, as higher doses significantly increase risk of ischemic complications. 1

  • Monitor for ischemic complications: decreased cardiac output, bradycardia, coronary/mesenteric/digital ischemia, and skin necrosis. 2

References

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vasopressor Dosing Threshold for Steroid Initiation in Sepsis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.